抗氧化剂对生物制药分类系统 (BCS) 缺乏作用 药物透性III类
Yuly Chiang Yu1, Dongmei Lu2, Bhagwant Rege2
1Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, 21201, USA.
Journal of pharmaceutical sciences
|March 14, 2024
概括
将抗氧化剂添加到固体口服剂型中,可以在不影响药物吸收的情况下防止尼托拉胺的形成. 测试了10种抗氧化剂,发现它们不会改变生物制药分类系统III类药物的肠道透性.
科学领域:
- 制药科学 制药科学
- 药物运输 药物运输 药物运输
- 药用化学 医学化学
背景情况:
- 尼胺杂质是制药产品的安全问题,特别是固体口服剂型.
- 抗氧化剂被探索为一种减轻尼托胺形成的策略.
- 了解抗氧化剂对药物透性的影响对于配方开发至关重要.
研究的目的:
- 评估十种不同的抗氧化剂对四种生物制药分类系统 (BCS) 第三类药物的肠道透性的影响.
- 为了确定抗氧化剂是否会干扰高透性药物的被动吸收.
- 评估将这些抗氧化剂纳入固体口服剂型的安全性.
主要方法:
- 在体外双向药物透性研究中,使用MDCK-II细胞单层进行了研究.
- 四种BCSIII类药物在缺少和存在十种抗氧化剂的情况下进行了透性测试.
- 硫酸作为阳性对照用于验证透性试验.
主要成果:
- 十种测试的抗氧化剂中没有一个增加了BCS III类药物的被动肠道透性.
- 阳性对照,硫酸,如预期的那样,始终增加了药物的透性.
- 抗氧化剂不会对选择的高透性药物的透性产生负面影响.
结论:
- 十个研究的抗氧化剂,在高达10毫克的度下,不会调节BCS III类药物的被动肠道透性.
- 这些抗氧化剂可能会被纳入固体口服剂型,而不会影响药物吸收.
- 关于在药物配方中使用抗氧化剂的进一步考虑是合理的.
相关概念视频
Hepatic Drug Clearance: Role of Transporters
56
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
56
Factors Influencing Drug Absorption: Drug Dissolution
486
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
486
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
207
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
207
Factors Affecting Drug Distribution: Tissue Permeability
197
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
197
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.3K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.3K
Factors Influencing Drug Absorption: Physicochemical Parameters
274
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
274


